JO1896B1 - Clavulanic acid salts - Google Patents

Clavulanic acid salts

Info

Publication number
JO1896B1
JO1896B1 JO19961896A JOP19961896A JO1896B1 JO 1896 B1 JO1896 B1 JO 1896B1 JO 19961896 A JO19961896 A JO 19961896A JO P19961896 A JOP19961896 A JO P19961896A JO 1896 B1 JO1896 B1 JO 1896B1
Authority
JO
Jordan
Prior art keywords
clavulanic acid
acid salts
salt
formula
salts
Prior art date
Application number
JO19961896A
Other languages
Arabic (ar)
Inventor
كالورات جورج
Original Assignee
سبوركورت ليمتد
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by سبوركورت ليمتد filed Critical سبوركورت ليمتد
Application granted granted Critical
Publication of JO1896B1 publication Critical patent/JO1896B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The salts are prepared by reacting a benshydrylamine of formula (I) (or a salt thereof) with clavulanic acid (or a salt thereof) in an organic solvent, and isolating the resulting salt. In formula (I), each of R1 and R2 is hydrogen (preferred) or an acceptable substituent. The clavulanic acid salts can be used in pharmaceutical formulations together with a pharmaceutically acceptable carrier, and, optionally, a beta-lactam antibiotic.
JO19961896A 1995-02-25 1996-02-25 Clavulanic acid salts JO1896B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9503839.4A GB9503839D0 (en) 1995-02-25 1995-02-25 Claulanic acid salt

Publications (1)

Publication Number Publication Date
JO1896B1 true JO1896B1 (en) 1996-07-25

Family

ID=10770268

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19961896A JO1896B1 (en) 1995-02-25 1996-02-25 Clavulanic acid salts

Country Status (4)

Country Link
KR (1) KR19980702445A (en)
AR (1) AR003408A1 (en)
GB (2) GB9503839D0 (en)
JO (1) JO1896B1 (en)

Also Published As

Publication number Publication date
AR003408A1 (en) 1998-08-05
KR19980702445A (en) 1998-07-15
GB9503839D0 (en) 1995-04-19
GB9520915D0 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
CA2130516A1 (en) New 11-benzaldoxime-estradiene derivatives, processes for their production and pharmaceuticals containing these substances
MX9804107A (en) Quinoline derivatives.
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
AU666702B2 (en) Morphinan derivative and medicinal use
AU4798000A (en) Triarylimidazoles
IE781878L (en) Imidazole derivatives
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
NO973744L (en) Klavulinsyresalter
MY131381A (en) Piperazine derivatives suitable for use as pharmaceuticals, in particular as 5-ht1a receptor binding agents.
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
ES2001773A6 (en) Cephalosporin derivatives.
AU1314295A (en) Anellated dihydropyridines and their use in the production of pharmaceutical preparations
MY114213A (en) Clavulanic acid salts
AU2407395A (en) Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
AP9701079A0 (en) Sulfonamides.
JO1896B1 (en) Clavulanic acid salts
GB1493233A (en) 7-alpha-(4-hydroxy-1,5-naphthyridine-3-carbonamido)-alpha-phenylacetamido cephalosporin derivatives
IE850161L (en) Penem derivatives and azetidinone intermediates
CA2107675A1 (en) Antibiotic carbapenem derivatives
YU12191A (en) CRYSTAL HYDROCHLORIDE OF A NEW BETA-LACTAM ANTIBIOTIC AND PROCEDURE FOR ITS OBTAINING
EP0476156A4 (en) Solid oral preparation containing catechol compound
GB1505859A (en) Azetidinone derivatives
IE812881L (en) Clavulanic acid derivatives
EP0271586A4 (en) -g(b)-LACTAM COMPOUNDS AND PROCESS FOR THEIR PREPARATION.